Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial

Published:2013-10-13 Issue:12 Volume:67 Page:1267-1282
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Wilding J. P. H.¹,Charpentier G.²,Hollander P.³,González‐Gálvez G.⁴,Mathieu C.⁵,Vercruysse F.⁶,Usiskin K.⁷,Law G.⁷,Black S.⁷,Canovatchel W.⁷,Meininger G.⁷

Affiliation:

1. Department of Obesity and Endocrinology University of Liverpool Liverpool UK

2. Department of Diabetes Sud‐Francilien Hospital Centre d'Études et de Recherche pour l'Intensification du Traitement du Diabète (CERITD) Corbeil‐Essonnes France

3. Baylor University Medical Center Dallas TX USA

4. Instituto Jalisciense de Investigacion en Diabetes y Obesidad Guadalajara Mexico

5. Clinical and Experimental Endocrinology KU Leuven Leuven Belgium

6. Janssen Research & Development Beerse Belgium

7. Janssen Research & Development LLC Raritan NJ USA

Funder

Janssen Research & Development, LLC

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.12322

Reference41 articles.

1. Standards of Medical Care in Diabetes—2012

2. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

3. Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added to Metformin Among Patients With Type 2 Diabetes

4. Effect of Antihyperglycemic Agents Added to Metformin and a Sulfonylurea on Glycemic Control and Weight Gain in Type 2 Diabetes: A Network Meta-analysis

5. Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes

Cited by 275 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2i effect on atrial fibrillation: A network meta‐analysis of randomized controlled trials;Journal of Cardiovascular Electrophysiology;2024-06-28

2. Transporter Proteins as Therapeutic Drug Targets—With a Focus on SGLT2 Inhibitors;International Journal of Molecular Sciences;2024-06-25

3. Quantitative analysis of low-content impurity crystal forms in canagliflozin tablets by NIR solid-state analysis technique;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-04

4. Sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis;Journal of Endocrinological Investigation;2024-03-26

5. Sodium glucose cotransporter 2 inhibitors with cardiac arrhythmias in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized placebo-controlled trials;Clinical Research in Cardiology;2024-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3